Blog
The Current State of Xylazine
The Current State of Xylazine What is Xylazine? A tranquilizer called xylazine has been increasingly found on the black market and associated...
The Current State of Xylazine
The Current State of Xylazine What is Xylazine? A tranquilizer called xylazine has...
Navigating Puerto Rico’s New Licensing Standards for Pharmaceutical Wholesale Distributors
Navigating Puerto Rico's New Licensing Standards for Pharmaceutical Wholesale...
1856 Regulatory Changes By Regulatory Agencies Since January 1st, 2024
1856 Changes By Regulatory Agencies Since January 1st, 2024 Regulatory agencies have...
Connecticut Reporting Transparency Updates
Connecticut Reporting Transparency Updates In 2018, Connecticut established the Office...
New Mexico Passes Prescription Drug Price Transparency Act | Effective 01/01/2025
New Mexico Passes Prescription Drug Price Transparency Act New Bill: HB0033AFS...
Supreme Court Ruling on Chevron Deference Threatens to Reshape the Regulatory Landscape
Supreme Court Ruling on Chevron Deference Threatens to Reshape the Regulatory Landscape...
Veteran’s Health Administration Announces New Trading Partner Requirements
Veteran’s Health Administration Announces New Trading Partner Requirements The...
Regulatory Recap of New State and Federal Regulation: February 2024
Regulatory Recap of New State & Federal Regulations In the dynamic landscape of...
Third Florida Development Paints a Clear Target on Pharma Pricing
Third Florida Development Paints a Clear Target on Pharma Pricing Three major...
State and Federal Regulatory Changes for January 2024
State and Federal Regulatory Changes for Early January 2024 As we begin our 2024...
2023 Letter from the CEO
Written by: Sumeet Singh | Founder & CEO 12/7/2023 Hello Everyone, It’s...
Antitrust Making Headlines: A Look at Past Litigation in Pharma & Pharma Services
Written by: Sumeet Singh | Chief Executive Officer The FTC is taking names...